| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 16.07M | — |
| Operating expense | — | — |
| Net income | -7.19M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, FHTX returned +27.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +30.9% |
| 1 year | +27.2% |
| 5 years | -45.5% |
| All-time high | $22.87 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in FHTX would be worth today ›No. Foghorn Therapeutics Inc. has not paid a dividend in the past 12 months.
Foghorn Therapeutics Inc. stock trades on NASDAQ under the ticker symbol FHTX.
Foghorn Therapeutics Inc. is part of the Healthcare sector.
Foghorn Therapeutics Inc. has a market cap of 419.85M USD, based on the latest quote.
Foghorn Therapeutics Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
